Medical Schools, Molecular Biology and Research

Advancements in upstream CLD for enhanced biotherapeutics production

Drug Discovery World

NOVEMBER 27, 2023

With more than 20 years of experience in business management, strategy, marketing, and product management, Anis also has research background from biotech, pharmaceutical, and premier academic organisations. [link] About the author Anis is within the strategy group in Life Sciences at Revvity, Inc.

Production

Production Engineering Molecular Biology Drug Development

Driving efficiency across upstream bioprocess workflow

Drug Target Review

MARCH 15, 2024

Disclaimer: For research use only. With more than 20 years of experience in business management, strategy, marketing and product management, Anis also has a research background in biotech, pharmaceutical and premier academic organisations.

Engineering

Engineering Molecular Biology Protein Expression Medical Schools

Mediating BRAF-mutant melanoma resistance

Drug Target Review

FEBRUARY 26, 2024

Alani currently serves as the Herbert Mescon Endowed Professor and Chair of Dermatology at Boston University Chobanian & Avedisan School of Medicine and the Dermatologist-in-Chief at Boston Medical Center, a position she has held since January, 2010. degree with Honors and Distinction in Research from the University of Michigan.

Therapies

Therapies Molecular Biology Regulations Medical Schools

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

AUGUST 29, 2024

Dr Siciliano received a BS in chemistry from Villanova University and shortly thereafter began his scientific career in the Department of Microbiology at the University of Pennsylvania Medical School studying host-pathogen interactions.

Therapies

Therapies Treatment Engineering Molecular Biology

A surprising new role for a major immune regulator

Broad Institute

AUGUST 7, 2023

Now, a team of MIT, Massachusetts General Hospital (MGH), Broad Institute of MIT and Harvard, and Harvard Medical School (HMS) researchers has discovered how STING activates those two pathways. Because of that, the researchers wondered if STING might somehow induce proton leakage.

Regulations

Regulations Engineering Clinical Trials DNA

GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director

The Pharma Data

OCTOBER 27, 2021

The appointment also builds on other recent Non-Executive Director appointments, including Charles (Charlie) Bancroft, former Executive Vice President at Bristol Myers Squibb (BMS), and Dr Anne Beal, former instructor in paediatrics at Harvard Medical School and Massachusetts General Hospital, and Chief Patient Officer at Sanofi.

Molecular Biology

Molecular Biology Science Medical Schools Disease

A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic

Broad Institute

APRIL 25, 2024

Partnering with researchers on the ground to reach communities where they are is absolutely critical to making that a reality.” “We Ozonoff is also an associate professor of pediatrics at Harvard Medical School and a scientist at Boston Children’s Hospital. We learned a lot from Ebola,” Happi said. “We

Virus

Virus Hospitals Disease Government

The use-case for NGS

Drug Discovery World

OCTOBER 25, 2023

DDW Editor Reece Armstrong speaks to Dr Darrell Green , Lecturer in RNA Biology Biomedical Research Centre Norwich Medical School University of East Anglia, about his work using next generation sequencing (NGS) and the areas the technology is impacting within drug discovery and development.

Bioinformatics

Bioinformatics Pharmacogenetics RNA Medical Schools

Battling antibiotic resistance in the lab and the clinic

Broad Institute

JANUARY 30, 2024

More bottles on the medicine shelf would help, but Bhattacharyya, who’s now also a research scientist, realized that science might lead to better tools for diagnosing and treating such challenging cases. TWO WHITE COATS Roby Bhattacharyya's mother, Maryka, visiting his graduate research lab at UCSF.

Hospitals

Hospitals Medical Schools Virus Science

Navigating the challenges of cell therapies

Drug Target Review

NOVEMBER 8, 2023

Vittoria was built on research conducted by Vittoria’s Scientific founder, Dr Marco Ruella, a physician-scientist and Assistant Professor of Medicine at the Center for Cellular Immunotherapies at Penn’s Perelman School of Medicine. About the author Dr Nicholas A. Dr Siciliano received a B.S. He then earned a Ph.D.

Therapies

Therapies Engineering Molecular Biology Treatment

Low oxygen levels restore balance and coordination in a mouse model of a movement disorder

Broad Institute

JUNE 21, 2023

Now, researchers at the Broad Institute of MIT and Harvard have found that treatment with continuous hypoxia — low-oxygen conditions comparable to levels at a Mount Everest base camp — restores balance and coordination in a mouse model of Friedreich’s ataxia. “If They also found that hypoxia restored iron-sulfur cluster levels in cells.

Molecular Biology

Molecular Biology Treatment Disease Medical Schools

SRP-001: redefining pain treatment with a safer, non-opioid analgesic

Drug Target Review

JULY 1, 2024

Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. He was bestowed the 2024 NIH HEAL Director’s Trailblazer Award for this work.

Treatment

Treatment Clinical Trials Molecular Biology Therapies

The role of anti-viral drug development in a new pandemic era

Drug Target Review

FEBRUARY 15, 2024

To survive this era, governments, multi-lateral organisations, foundations, and industry will need to work collectively on researching and developing new drugs that can prevent or treat a broad range of epidemic-prone pathogens, some of which have not yet been identified. All of these factors are being further accelerated by climate change.

Drug Development

Drug Development Virus Vaccine Government

Codon Digest: Hackathon Prize Winners

Codon

JUNE 26, 2023

Goodsell, Scripps Research and RCSB Protein Data Bank. And for another study, researchers engineered bacteriophage T4 to target and deliver payloads to human cells , simply by swapping around the proteins on their outer shells and then coating them in positively-charged lipid molecules. “Every query is like $2.”

DNA

DNA Therapies Engineering Clinical Trials

Codon Digest: Hackathon Prize Winners

Codon

JUNE 26, 2023

Goodsell, Scripps Research and RCSB Protein Data Bank. And for another study, researchers engineered bacteriophage T4 to target and deliver payloads to human cells , simply by swapping around the proteins on their outer shells and then coating them in positively-charged lipid molecules. “Every query is like $2.”

DNA

DNA Therapies Engineering Clinical Trials

Drug Discovery Digest

Advancements in upstream CLD for enhanced biotherapeutics production

Driving efficiency across upstream bioprocess workflow

Trending Sources

Mediating BRAF-mutant melanoma resistance

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

A surprising new role for a major immune regulator

GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director

A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic

The use-case for NGS

Battling antibiotic resistance in the lab and the clinic

Navigating the challenges of cell therapies

Low oxygen levels restore balance and coordination in a mouse model of a movement disorder

SRP-001: redefining pain treatment with a safer, non-opioid analgesic

The role of anti-viral drug development in a new pandemic era

Codon Digest: Hackathon Prize Winners

Codon Digest: Hackathon Prize Winners

Stay Connected